BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $810 Price Target

Benzinga · 2d ago
BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $810 price target.